A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RVO / retinal vein occlusion

[Related PubMed/MEDLINE]
Total Number of Papers: 831
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RVO  (>> Co-occurring Abbreviation)
Long Form:   retinal vein occlusion
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 A Joint Model for Macular Edema Analysis in Optical Coherence Tomography Images Based on Image Enhancement and Segmentation. OCT
2021 Accuracy of automated machine learning in classifying retinal pathologies from ultra-widefield pseudocolour fundus images. AI, AUPRC, AutoML, RD, RP, UWF
2021 Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry. BRAO, BRVO, CRAO, CRVO, IRIS, PRAO, RAO, TRAO, VE
2021 Anatomic-Functional Correlates in Lesions of Retinal Vein Occlusion. IRF, NICRF
2021 Association of Retinal Vascular Manifestation and Obstructive Sleep Apnea (OSA): A Narrative Review. CSC, DR, HTRP, OSA
2021 Bilateral Retinal Vein Occlusion-Simulated Coats' Disease. ---
2021 Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections. AMD, DME, logMAR, mCNV, RRDs, VEGF
2021 Clinical Characteristics of Paracentral Acute Middle Maculopathy in Eyes with Retinal Vascular Occlusion Diseases in Chinese Patients. OCT, p-MLM, PAMM, RAO
10  2021 Clinical efficacy and safety of Razumab® (CESAR) study: Our experience with the world's first biosimilar Ranibizumab. CDVA, CESAR, CFT, CNVM, DME, IOP
11  2021 Clinical significance of subclinical atherosclerosis in retinal vein occlusion. baPWV, CI, LDL-C, OR
12  2021 Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice. anti-VEGF, BCVA, CMT, DMO, nAMD
13  2021 Correlation between the Nonperfusion Area on Ultra-Widefield Fluorescein Angiography and Nonflow Area on Optical Coherence Tomographic Angiography in Retinal Vein Occlusion. DCP, FAZ, ISI, NFA, NPA, OCTA, SCP, UWFFA, VD
14  2021 Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity. DMO, nAMD, OCT, RCOphth, VA
15  2021 Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea. BCVA, DEX
16  2021 Discontinuation and loss to follow-up rates in clinical trials of intravitreal anti-vascular endothelial growth factor injections. AMD, anti-VEGF, DME, LTFU
17  2021 Effectiveness of Microcurrent Stimulation in Preserving Retinal Function of Blind Leading Retinal Degeneration and Optic Neuropathy: A Systematic Review. AMD, EPT, ERG, ES, RAO, RCTs, RP, rtACS, TcES, TdES, TpES, VA, VF
18  2021 Efficacy of intravitreal ziv-aflibercept in patients with macular edema following retinal vein occlusion in Korle-Bu Teaching Hospital, Ghana: a retrospective case series. BCVA, CSFT, IVZ, ME
19  2021 Establishment of a pigmented murine model abundant with characteristics of retinal vein occlusion. VEGF
20  2021 Evaluation of acquired color vision deficiency in retinal vein occlusion using the Rabin cone contrast test. CCT, CVD, RCCT, SPP-2
21  2021 Evaluation of macular microvasculature and foveal avascular zone in patients with retinal vein occlusion using optical coherence tomography angiography. CCP, DCP, FAZ, OCTA, SCP
22  2021 Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion. anti-VEGF, BCVA, GON
23  2021 Excess adiponectin in eyes with progressive ocular vascular diseases. OIR, VEGF
24  2021 Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases. DME, VEGF, wAMD
25  2021 Fatty acid-binding protein 4 is an independent factor in the pathogenesis of retinal vein occlusion. FABP4, LSFG, MBR, ONH, VEGFA
26  2021 Five-Category Intelligent Auxiliary Diagnosis Model of Common Fundus Diseases Based on Fundus Images. AUC, CI, DR
27  2021 How Traumatic is Intravitreal Ozurdex Injection? DEX, PG
28  2021 Impact of kidney transplantation on the risk of retinal vein occlusion in end-stage renal disease. ESRD, KT
29  2021 Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series. BCVA, CMT, DME, nAMD
30  2021 Intravitreal Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusion. BCVA, CMT, IVB
31  2021 Is retinal vein occlusion associated with depression symptoms?: A nationwide cohort study. CI
32  2021 KSI-301: antibody biopolymer conjugate in retinal disorders. AMD, DME, VEGF
33  2021 Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. VEGF
34  2021 Longitudinal Changes on Optical Coherence Tomography Angiography in Retinal Vein Occlusion. AFI, FAZ, OCTA, VD, VEGF, VLD
35  2021 Machine Learning Can Predict Anti-VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema. AUC, DME, nAMD, TER, VEGF
36  2021 Mechanical Thrombectomy in Distal Residual Occlusions of the Middle Cerebral Artery after Large Vessel Recanalization in Acute Stroke: 2b or not 2b? A Pragmatic Approach in Real-Life Scenarios. mRS, mTICI
37  2021 Methylenetetrahydrofolate reductase polymorphisms as risk factors for retinal venous occlusive disease: A literature review. MTHFR
38  2021 Microvascular comparison in younger and older patients with retinal vein occlusion analyzed by OCT angiography. BCVA, FAZ, VD
39  2021 Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model. FFA, NV, OIR, PDR, ROP, VO
40  2021 Multi-Compartment Spatially-Derived Radiomics From Optical Coherence Tomography Predict Anti-VEGF Treatment Durability in Macular Edema Secondary to Retinal Vascular Disease: Preliminary Findings. AUC, DME, LDA, QDA, RF, SD-OCT, SVM, VEGF
41  2021 Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion. ME, OCT, OCTA, VEGF
42  2021 Multimodal imaging of two cases of retinal vein occlusion secondary to Waldenstrom macroglobulinemia. BCVA, ME, OCT, OCTA, WM
43  2021 Obstructive Sleep Apnea is Related with the Risk of Retinal Vein Occlusion. 8-OHdG, AHI, BRVO, CRP, CRVO, IL-1beta, IL-6, ME, NVG, OSA, PSG, TNF-alpha
44  2021 Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review. CAR, CME, DME, DRN, FAc, MAR, RM, RP
45  2021 Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability. ---
46  2021 Oral administration of NSP-116, a free radical scavenger, suppresses the symptoms of retinal vein occlusion in the murine model. TNF, VEGF
47  2021 Outcomes of Combination Therapy using Aflibercept and Dexamethasone Intravitreal Implant versus Dexamethasone Monotherapy for Macular Edema Secondary to Retinal Vein Occlusion. BCVA, CMT, logMAR, ME
48  2021 Outcomes of eyes with retinal vein occlusion that are lost to follow-up after antivascular endothelial growth factor therapy. CFT, LTFU, VA, VEGF
49  2021 Peripapillary Microvasculature of the Retina and Choriocapillaris in Uninvolved Fellow Eyes of Unilateral Retinal Vein Occlusion Patients. DCP, RPCP, SCP
50  2021 Photocoagulation for retinal vein occlusion. BRVO, CRVO, NV, NVG
51  2021 Platelet and Thrombophilia-Related Risk Factors of Retinal Vein Occlusion. MPV, P-LCR, PDW
52  2021 Quality of Life among Patients with Retinal Vein Occlusion: A Case-Control Study. ---
53  2021 Rapid reduction of macular edema due to retinal vein occlusion with low-dose normobaric hyperoxia. CMT, MMT, NBH
54  2021 Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion. CRT, IOP, ME, VA
55  2021 Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion. BRVO, CRVO, DEX
56  2021 Repeatability of Optical Coherence Tomography Angiography Measurements in Patients with Retinal Vein Occlusion. CV, DCP, FAZ, ICC, OCTA, SCP, VD
57  2021 Retinal venous pressure is decreased after anti-VEGF therapy in patients with retinal vein occlusion-related macular edema. BRVOs, CRT, CRVOs, IOP, IVR, RVP, VA, VEGF
58  2021 Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysis. ---
59  2021 Short-term effectiveness prognostic factors after dexamethasone intravitreal implant in macular edema due to retinal vein occlusion. BCVA, CMT, CMV, ETDRS, IDI, ME
60  2021 Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study. eGFR, HRs, OGLDs, SGLT2
61  2021 Standardization of OCT Angiography Nomenclature in Retinal Vascular Diseases: First Survey Results. DMI, DR, FAZ, NV, OCTA
62  2021 Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab. BCVA, CRT, ETDRS, VEGF
63  2021 The association between circulating neutrophil extracellular trap related biomarkers and retinal vein occlusion incidence: A case-control pilot study. cfDNA, MPO, NETs, ROC
64  2021 The association of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with retinal vein occlusion: a systematic review and meta-analysis. CI, CrI, NLR, PLR
65  2021 The Effect of Delay in Care among Patients Requiring Intravitreal Injections. DME, IVIs, nAMD, PDR, SE, VA
66  2021 The effect of intravitreal dexamethasone implant on central foveal thickness and choroidal thickness in retinal vein occlusion. DEX, OCT
67  2021 The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown. BCVA, DME, SD-OCT, wet-AMD
68  2021 The Nationwide Incidence of Retinal Vein Occlusion Following Dialysis due to End-stage Renal Disease in Korea, 2004 through 2013. ESRD, PY
69  2021 The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections. BCVA, CMT, FU, IVTS, ME, OCT, RVMA, VMA
70  2021 Time course of collateral vessel formation after retinal vein occlusion visualized by OCTA and elucidation of factors in their formation. mRNA, OCTA, qRT-PCR, S1PR1
71  2021 Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World's First Biosimilar Ranibizumab): A Comprehensive Review. DME, mCNV
72  2021 Treatment outcomes of retinal vein occlusion in clinical practice in Nepal. BRVO, CI, CRVO, CST, VA
73  2021 Treatment patterns for retinal diseases in patients newly-treated with anti-VEGF agents: A retrospective analysis of claims data from the Japan Medical Data Center database. anti-VEGF, DME, JMDC, nAMD
74  2021 Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis. DVT, PE, VTE
75  2021 Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor. DME
76  2021 Vitamin B12 and Folate as Risk Factors for Retinal Vein Occlusion: A Meta-Analysis. ---
77  2021 Vitreoretinal Society of India practice pattern survey 2020: Medical retina. CSCR, DR, nAMD, PCV, RCTs, VRSI
78  2021 Wide-Field Fluorescein Angiography in the Diagnosis and Management of Retinal Vein Occlusion: A Retrospective Single-Center Study. OCT, WFFA
79  2021 [Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion]. VRF
80  2021 [Real life retrospective study of 98 eyes treated with intravitreal dexamethasone or anti-VEGF injections for macular edema due to diabetes or retinal vein occlusion]. DME
81  2020 A Comparison of Manual and Robot Assisted Retinal Vein Cannulation in Chicken Chorioallantoic Membrane. CAM, RVC
82  2020 A Multicenter, Retrospective Study (RE-ENACT2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion. CSFT, IOP, IRF, PRN, RE-ENACT2, SRF
83  2020 A novel tool to assess the quality of RWE to guide the management of retinal disease. DME, GRACE, nAMD, RWE
84  2020 Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report. ARN, ME
85  2020 Age-related differences in presentation and outcomes of anti-VEGF treatment of retinal vein occlusion. CST, VA, VEGF
86  2020 Altered intrinsic functional connectivity of the primary visual cortex in patients with retinal vein occlusion: a resting-state fMRI study. FC, HCs, ROC, rs-fMRI
87  2020 Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion. APS
88  2020 Assessment of platelet-to-lymphocyte ratio in patients with retinal vein occlusion. PLR
89  2020 Assessment of pupillary light reflex using dynamic pupillometry in laser-treated eyes with retinal vein occlusion. BRVO, CRVO
90  2020 Association between Early Anatomic Response and Intraocular Pressure Change after Intravitreal Dexamethasone Implant: An Optical Coherence Tomography Study. CST, DEX, IIOP, IOP, ME, nIIOP
91  2020 Association of Retinal Vascular Occlusion With Women Filling a Prescription for Female Hormone Therapy. FHT, HR, RAO
92  2020 Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy. anti-VEGF, DME, IRF, nAMD, SRF
93  2020 Automated Quantification of Photoreceptor alteration in macular disease using Optical Coherence Tomography and Deep Learning. DME
94  2020 Automated segmentation of retinal nonperfusion area in fluorescein angiography in retinal vein occlusion using convolutional neural networks. CNNs, FA, RNP
95  2020 Bilateral Central Retinal Vein Occlusion in a 40-Year-Old Man with Severe Coronavirus Disease 2019 (COVID-19) Pneumonia. COVID-19, SARS-CoV-2
96  2020 Cellular and Molecular Aspects of Blood Cell-Endothelium Interactions in Vascular Disorders. AGEs, GP, ICAM, PV, RBCs, VCAM
97  2020 Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion. CRT, EDI-OCT, IVA, VA
98  2020 Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion. aVEGF
99  2020 Choroidal thickening in retinal vein occlusion patients with serous retinal detachment. BRVO, CRVO, CSCT, CSFT, SRD, SS-OCT, VEGF
100  2020 Choroidal vascularity index and choriocapillary changes in retinal vein occlusions. CVI, OCT, OCTA